TD Asset Management »

Stoke Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4M 74k 32.56
2023-06-30 $278k 26k 10.63
2023-03-31 $218k 26k 8.33
2022-12-31 $242k 26k 9.23
2022-09-30 $341k 26k 13.02
2022-06-30 $459k 35k 13.22
2022-03-31 $731k 35k 21.06
2021-12-31 $833k 35k 24.00
2021-09-30 $741k 29k 25.45
2021-06-30 $834k 29k 28.65
2021-03-31 $1.4M 37k 38.85
2020-12-31 $1.9M 31k 61.93
2020-09-30 $746k 22k 33.48
2020-06-30 $531k 22k 23.83
2020-03-31 $510k 22k 22.89
2019-12-31 $563k 20k 28.32
2019-09-30 $427k 20k 21.48